The Rs 800 crore Elder Pharmaceuticals Limited and maker of brands like the calcium supplement ShelCal, expects to launch about 35 new products in the next 30 months. The products would be in therapeutic areas like female healthcare, osteoporosis, dermatology, pain management, cardiology, nutraceuticals, wound care and vitamin supplements, the company said. The products would be through a combination of in-licensed and owned products although the larger focus will be on self-researched products.
Elder Pharma is targeting a turnover of Rs 1500 crore by 2013 and has research centre at Navi Mumbai, staffed by about 100 scientists.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.